Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 3Genitourinary 3Endocrine 2Breast 2Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Neoplasms 1Melanoma 1Lung Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Desflurane × Genitourinary × Clear all
NCT04074460 2022-06-09

VAPOR-C

Peter MacCallum Cancer Centre, Australia

Phase 4 Completed
169 enrolled
BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT02149628 2015-07-29

The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide

Yonsei University

Phase 4 Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

NCT02096224 2014-10-02

Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort

Seoul National University Hospital

Phase NA Completed
108 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡